Nuvo Research, Inc. (OTC: NRIFF) is a life sciences company with a diverse portfolio of products and technologies. In September, Nuvo announced that it plans to split Nuvo into two separate, publicly traded companies. Under the proposed plan, one company, to be known as Nuvo Pharmaceuticals Inc., will be a commercial healthcare company that will own the company’s Pennsaid and Pennsaid 2% franchises and related assets.  The other company, to be known as Crescita Therapeutics Inc., will be a development company that will own the company’s existing drug development business including its pipeline of product candidates. For more information, visit the company’s website at www.nuvoresearch.com